These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32641106)

  • 1. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
    Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
    Clin Epigenetics; 2020 Jul; 12(1):102. PubMed ID: 32641106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
    Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
    Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
    Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
    PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic DNA methylation landscape of the
    Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
    Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.
    Savio AJ; Bapat B
    Epigenetics; 2017 Jun; 12(6):441-448. PubMed ID: 28304185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
    [No Abstract]   [Full Text] [Related]  

  • 8. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
    Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
    BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
    Simpkins SB; Bocker T; Swisher EM; Mutch DG; Gersell DJ; Kovatich AJ; Palazzo JP; Fishel R; Goodfellow PJ
    Hum Mol Genet; 1999 Apr; 8(4):661-6. PubMed ID: 10072435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLH1-93G > A is a risk factor for MSI colorectal cancer.
    Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
    Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.
    Moreira L; Muñoz J; Cuatrecasas M; Quintanilla I; Leoz ML; Carballal S; Ocaña T; López-Cerón M; Pellise M; Castellví-Bel S; Jover R; Andreu M; Carracedo A; Xicola RM; Llor X; Boland CR; Goel A; Castells A; Balaguer F;
    Cancer; 2015 May; 121(9):1395-404. PubMed ID: 25557234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.
    Haruma T; Nagasaka T; Nakamura K; Haraga J; Nyuya A; Nishida T; Goel A; Masuyama H; Hiramatsu Y
    PLoS One; 2018; 13(4):e0195655. PubMed ID: 29659608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
    Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
    Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.
    Cosgrove CM; Cohn DE; Hampel H; Frankel WL; Jones D; McElroy JP; Suarez AA; Zhao W; Chen W; Salani R; Copeland LJ; O'Malley DM; Fowler JM; Yilmaz A; Chassen AS; Pearlman R; Goodfellow PJ; Backes FJ
    Gynecol Oncol; 2017 Sep; 146(3):588-595. PubMed ID: 28709704
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Carnevali IW; Cini G; Libera L; Sahnane N; Facchi S; Viel A; Sessa F; Tibiletti MG
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
    Horowitz N; Pinto K; Mutch DG; Herzog TJ; Rader JS; Gibb R; Bocker-Edmonston T; Goodfellow PJ
    Gynecol Oncol; 2002 Jul; 86(1):62-8. PubMed ID: 12079302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
    Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
    Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
    PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.